92915-79-2 (OVA (323-339),OVA Peptide (323-339))

CAS号:
92915-79-2
中文名称:
OVA (323-339)
英文名称:
OVA Peptide (323-339)
分子式:
C74H120N26O25
分子量:
1773.90381526947
简介:
OVA Peptide (323-339) 代表卵清蛋白(OVA)的T和B细胞表位,这对于BALB/c小鼠的瞬时超敏反应的产生和发展是重要的。

OVA (323-339)(92915-79-2)名称与标识符

名称

中文别名:
卵清蛋白肽;
英文别名:
L-Arginine,L-isoleucyl-L-seryl-L-glutaminyl-L-alanyl-L-valyl-L-histidyl-L-alanyl-L-alanyl-L-histidyl-L-alanyl-L-a-glutamyl-L-isoleucyl-L-asparaginyl-L-a-glutamyl-L-alanylglycyl-;H-ILE-SER-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-ILE-ASN-GLU-ALA-GLY-ARG-OH;ILE-SER-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-ILE-ASN-GLU-ALA-GLY-ARG;L-Arginine,L-isoleucyl-L-seryl-L-glutaminyl-L-alanyl-L-valyl-L-histidyl-L-alanyl-L-alanyl-L-hi...;L-Arginine,L-isoleucyl-L-seryl-L-glutaminyl-L-alanyl-L-valyl-L-histidyl-L-alanyl-L-alanyl-L-histidyl-L-alanyl-L-a-glutamyl-L-;OVA (323-339);OVALBUMIN (323-339) (CHICKEN, JAPANESE QUAIL);H2N-ISQAVHAAHAEINEAGR-OH;ISQAVHAAHAEINEAGR;OVA (323-339) (CHICKEN,JAPANESE QUAIL);OvalbuMin (323-339) (chicken,japanese quail) OVA (323-339) (chicken,japanese quail);OVALBUMIN CHICKEN (323-339);L-Isoleucyl-L-seryl-L-glutaminyl-L-alanyl-L-valyl-L-histidyl-L-alanyl-L-alanyl-L-histidyl-L-alanyl-L-α-glutamyl-L-isoleucyl-L-asparaginyl-L-α-glutamyl-L-alanylglycyl-L-arginine (ACI);L;102: PN: WO2009086539 SEQID: 76 unclaimed protein;105: PN: WO2012066495 SEQID: 118 unclaimed protein;107: PN: WO2010068680 SEQID: 91 claimed sequence;10: PN: US20080241228 SEQID: 10 claimed protein;10: PN: US8530153 SEQID: 10 unclaimed protein;10: PN: WO2012054584 SEQID: 10 claimed protein;114: PN: US20060002947 SEQID: 131 unclaimed protein;11: PN: WO03015716 SEQID: 3 claimed protein;11: PN: WO2012027200 SEQID: 11 unclaimed sequence;128: PN: US20090093050 SEQID: 137 unclaimed protein;12: PN: JP2008056647 SEQID: 12 claimed protein;130: PN: WO2011026122 SEQID: 138 unclaimed protein;130: PN: WO2011026132 SEQID: 138 unclaimed protein;133: PN: US20120178139 SEQID: 87 unclaimed sequence;134: PN: WO2011040978 PAGE: 50 unclaimed sequence;14: PN: WO2009101207 SEQID: 14 unclaimed sequence;15: PN: US20100278814 SEQID: 17 unclaimed protein;161: PN: WO2013044419 SEQID: 187 unclaimed protein;168: PN: US20120076808 SEQID: 187 unclaimed protein;16: PN: WO2013089252 SEQID: 16 unclaimed protein;18: PN: WO0072876 SEQID: 18 unclaimed protein;18: PN: WO2014053521 SEQID: 18 claimed sequence;19: PN: WO2009065561 SEQID: 16 unclaimed sequence;1: PN: CN101942013 SEQID: 4 claimed sequence;1: PN: CN104107428 PAGE: 2 claimed sequence;1: PN: EP1908821 SEQID: 1 unclaimed sequence;1: PN: EP2062592 SEQID: 16 unclaimed sequence;1: PN: EP2407177 SEQID: 1 unclaimed protein;1: PN: JP6121597 SEQID: 15 claimed sequence;1: PN: US20040253632 SEQID: 1 claimed protein;1: PN: US20200072837 SEQID: 10 claimed sequence;1: PN: WO03006055 FIGURE: 1 unclaimed protein;1: PN: WO2004069182 SEQID: 3 unclaimed protein;1: PN: WO2008059900 PAGE: 11 claimed sequence;1: PN: WO2008150868 SEQID: 1 unclaimed sequence;1: PN: WO2009023055 SEQID: 1 unclaimed sequence;1: PN: WO2009035600 SEQID: 1 unclaimed sequence;1: PN: WO2012150478 SEQID: 1 unclaimed protein;1: PN: WO2016021605 SEQID: 17 claimed sequence;1: PN: WO2023068376 SEQID: 1 claimed protein;22: PN: WO0037102 TABLE: 1 unclaimed protein;26: PN: US20160074509 SEQID: 26 claimed protein;26: PN: WO2012024621 SEQID: 26 claimed protein;27: PN: WO2011063264 SEQID: 26 unclaimed protein;292: PN: WO2012044999 SEQID: 292 claimed sequence;29: PN: WO2004041067 SEQID: 24 unclaimed protein;2: PN: KR20150088597 SEQID: 5 claimed protein;2: PN: US20060051374 SEQID: 2 unclaimed protein;2: PN: US20060233750 SEQID: 2 unclaimed protein;OVA Peptide (323-339);Ovalbumin (323-339) (chicken, japanese quail) (H-Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-Ala-Gly-Arg-OH);MFCD02181011;OVA323-339;Ovalbumin 323-339 chicken japanese quail;92915-79-2;F85542;Ovalbumin peptide(323-339);

标识符

MDL:
MFCD02181011
InChIKey:
GSSMIHQEWAQUPM-AOLPDKKJSA-N
Inchi:
1S/C74H120N26O25/c1-12-33(5)55(77)70(121)98-49(29-101)69(120)94-42(16-19-50(75)102)63(114)88-39(11)62(113)99-56(32(3)4)71(122)96-47(24-41-27-81-31-85-41)67(118)89-36(8)59(110)86-37(9)61(112)95-46(23-40-26-80-30-84-40)66(117)90-38(10)60(111)92-44(18-21-54(107)108)65(116)100-57(34(6)13-2)72(123)97-48(25-51(76)103)68(119)93-43(17-20-53(105)106)64(115)87-35(7)58(109)83-28-52(104)91-45(73(124)125)15-14-22-82-74(78)79/h26-27,30-39,42-49,55-57,101H,12-25,28-29,77H2,1-11H3,(H2,75,102)(H2,76,103)(H,80,84)(H,81,85)(H,83,109)(H,86,110)(H,87,115)(H,88,114)(H,89,118)(H,90,117)(H,91,104)(H,92,111)(H,93,119)(H,94,120)(H,95,112)(H,96,122)(H,97,123)(H,98,121)(H,99,113)(H,100,116)(H,105,106)(H,107,108)(H,124,125)(H4,78,79,82)/t33-,34-,35-,36-,37-,38-,39-,42-,43-,44-,45-,46-,47-,48-,49-,55-,56-,57-/m0/s1
SMILES:
[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)O)CCCNC(N)=N)CC1NC=NC=1)(NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)CC1NC=NC=1

OVA (323-339)(92915-79-2)物化性质

实验特性

  • LogP : -0.76190
  • PSA : 829.19000

计算特性

  • 精确分子量 : 1772.89000
  • 氢键供体数量 : 28
  • 氢键受体数量 : 51
  • 可旋转化学键数量 : 75
  • 同位素质量 : 1772.8917934g/mol
  • 重原子数量 : 125
  • 复杂度 : 3800
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 18
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -9.9
  • 拓扑分子极性表面积 : 829Ų

OVA (323-339)(92915-79-2)推荐厂家 更多厂家(10)

OVA (323-339)(92915-79-2)合成路线

合成路线:1 步
参考文献:
Nanoparticles comprising autoantigenic or allergenic or antigenic T cell receptor epitopes or peptides covalently linked to amphiphilic polymer for prevention and treatment of allergy, autoimmune disease, food or transplant intolerance
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
A Prodomain Peptide of Plasmodium falciparum Cysteine Protease (Falcipain-2) Inhibits Malaria Parasite Development
Korde, Reshma; Bhardwaj, Ashima; Singh, Rita; Srivastava, Anand; Chauhan, Virander S.; et al, Journal of Medicinal Chemistry, 2008, 51(11), 3116-3123
合成路线:1 步
参考文献:
Hmgb1-derived peptides enhance immune response to antigens
, United States, , ,
合成路线:1 步
参考文献:
Haptenization of ovalbumin with the skin sensitizer methyl octanesulfonate: characterization of the methylated OVA323-339 T-cell epitope at His331
Henriot, Stephanie; Lepoittevin, Jean-Pierre; Trifilieff, Elisabeth, Journal of Peptide Science, 2001, 7(6), 331-337